Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biohaven
Biohaven
Why Glaxo should buy Biohaven
EP Vantage
Fri, 07/9/21 - 09:46 am
Biohaven
GSK
Nurtec
migraines
M&A
Biohaven Leaps After Posting $93M Sales for Migraine Drug
TheStreet.com
Wed, 07/7/21 - 12:00 pm
Biohaven
migraines
Nurtec
Eli Lilly pins injectable migraine med Emgality against Biohaven's oral rival Nurtec ODT in head-to-head study
Fierce Pharma
Tue, 06/15/21 - 10:35 am
Eli Lilly
Emgality
migraines
Biohaven
Nurtec
Biohaven earns preventative nod for migraine med Nurtec, snaring a much-needed leg up over AbbVie
Endpoints
Fri, 05/28/21 - 11:16 am
Biohaven
FDA
migraines
Nurtec
AbbVie
Another Kardashian FDA letter: Biohaven smacked for Khloe's Nurtec migraine med claims
Fierce Pharma
Wed, 03/10/21 - 11:13 am
Biohaven
Nurtec
celebrity endorsements
FDA
Biohaven Provides Update On Phase 2/3 Trial And Alzheimer's Disease Program
BioSpace
Mon, 01/18/21 - 01:13 pm
Biohaven
Alzheimer's disease
clinical trials
troriluzole
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Fierce Pharma
Tue, 01/5/21 - 10:52 pm
Eli Lilly
Amgen
migraines
Allergan
Novartis
Biohaven
Teva Pharmaceutical
Eli Lilly, squaring off against AbbVie and Biohaven, touts data showing early and lasting migraine relief from Reyvow
Fierce Pharma
Fri, 09/11/20 - 12:11 pm
Eli Lilly
migraines
clinical trials
Reyvow
Biohaven
AbbVie
Biohaven adds nearly $1B in Nurtec deals with Royalty Pharma, Sixth Street
Endpoints
Fri, 08/7/20 - 11:05 am
Biohaven
Nurtec
Royalty Pharma
Sixth Street
AbbVie preps a challenge to a rival migraine drug from Biohaven, spelling out an upbeat set of PhIII data
Endpoints
Thu, 07/30/20 - 10:56 am
AbbVie
migraine
Nurtec
atogepant
Biohaven
Alzheimer’s catalysts round off a year dominated by Biogen
EP Vantage
Fri, 07/17/20 - 11:17 am
Alzheimer's disease
Roche
Eli Lilly
AC Immune
Biohaven
Cortexyme
Biogen
Biohaven hits social media jackpot with superceleb Khloe Kardashian as spokesperson for migraine med Nurtec ODT
Fierce Pharma
Thu, 07/16/20 - 11:22 pm
Biohaven
migraines
social media
celebrity endorsements
Nurtec ODT
Docs 'excited' to learn more about new migraine drugs from Biohaven, Lilly and AbbVie: analyst
Fierce Pharma
Thu, 06/25/20 - 10:53 am
migraines
physicians
Biohaven
Eli Lilly
AbbVie
Nurtec ODT
Ubrelvy
Reyvow
Biohaven fails OCD trial but pushes on to phase 3 regardless
Fierce Biotech
Wed, 06/24/20 - 10:54 am
Biohaven
OCD
clinical trials
troriluzole
Ex-biotech chief pleads guilty in college admissions scandal, faces a 10-month prison stretch in plea deal
Endpoints
Tue, 05/26/20 - 10:04 pm
Harmony Biosciences
scandal
Biohaven
Bob Repella
Covid-19 adds a new danger to drug launches
EP Vantage
Fri, 04/17/20 - 10:46 am
drug launches
pandemic
COVID-19
Esperion
Biohaven
Urogen
Biohaven embraces digital to keep migraine launch on track despite COVID-19
Fierce Pharma
Wed, 03/25/20 - 11:54 pm
Biohaven
migraines
drug launches
digital pharma
COVID-19
pandemic
Nurtec
Biohaven scores CGRP OK for acute migraine — can the commercial team catch up with Allergan on its debut?
Endpoints
Thu, 02/27/20 - 11:46 pm
Biohaven
FDA
migraines
Nurtec
Allergan
AbbVie
Ubrelvy
In final report, ICER appears to have a change of heart on new acute migraine therapies
Endpoints
Tue, 02/25/20 - 10:40 am
ICER
migraines
Biohaven
Allergan
ubrogepant
rimegepant
Eli Lilly
Lasmiditan
New Meds Set to Reshape US CNS and oncology Markets
Xconomy
Tue, 02/18/20 - 08:36 pm
CNS
oncology
cancer
Clarivate Analytics
Biohaven
rimegepant
Novartis
OMB-157
Pages
« first
‹ previous
1
2
3
4
next ›
last »